You are subscribed to the Dermatology Times eNews.

Dermatology Times eNews

eNewsletter Subscribe

Print Subscribe

Digital Edition Subscribe

December 24, 2014

Web Version  |  Digital Edition  |  Share with a colleague

Facebook Like   Twitter Tweet

HAPPY HOLIDAYS FROM DERMATOLOGY TIMES

An investigational vaccine may fight MRSA

In an experimental model, the investigational NDV-3 vaccine appears to mobilize the immune system to fight methicillin-resistant Staphylococcus aureus (MRSA) skin infections. » The vaccine's effect on S. aureus

Share » facebook twitter LinkedIn Google+

ADVERTISEMENT

Botulinum toxin injections: Cosmetic & Therapeutic treatment options
Botulinum toxin have a variety of medical uses, including smoothing out frown lines and treating pain. Articles, video, tools, and CME to help you stay up-to-date on the latest medical advances involving neurotoxins . Read More

Antipsychotic drug linked to rare but potentially fatal skin reactions

The antipsychotic drug ziprasidone is associated with rare but potentially fatal skin reactions, the FDA announced December 11, 2014. » Dermatologists should note these symptoms

Share » facebook twitter LinkedIn Google+

Acquisition breathes new life into Allergan's R&D efforts

The recently announced acquisition of Allergan Inc. by Actavis means the Irvine, Calif.-based maker of Botox will no longer be the target of a hostile takeover by Canadian firm Valeant Pharmaceuticals—which in turn means Allergan's research-and-development programs will continue unabated. » What's next?

Share » facebook twitter LinkedIn Google+

Texting improves compliance

Text messages improve compliant use of prescribed blood pressure and cholesterol-lowering medications, according to new research from Queen Mary University of London. » What the findings confirm

Share » facebook twitter LinkedIn Google+

RELATED COVERAGE

Compliance is shockingly understudied

Can my text to a patient lead to a HIPAA violation?

Warning about allergic reactions to acne treatments

FDA approves tedizolid phosphate for acute skin infections

FDA approves dalbavancin for acute skin infections

New Job Opportunities

AZ •Arizona Skin & Laser

CA •Integrated Dermatology

CA •Integrated Dermatology

CA •LA Laser Center

CT •Integrated Dermatology

CO •Integrated Dermatology

CO •Integrated Dermatology

District of Columbia •Integrated Dermatology

FL •Betty Bellman, MD PA

FL •First Coast Mohs

FL •Integrated Dermatology

FL •Integrated Dermatology

FL •Palm Beach Dermatology

IL •Integrated Dermatology

MI •Dermatology at MidTowne,PC

New Job Opportunities

National •Leavitt Management Group

NC •Integrated Dermatology

NJ •David A High, MD

NY •Skin Laser & Surgery Specialists of NY/NJ

NV •Integrated Dermatology

NY •Company Confidential

NY •Garden City Dermatology PC

OR •Cynthia Dreyer MD

PA •Dermatology Associates of Lancaster

UT •Integrated Dermatology

WI •Gundersen Lutheran Health System

WI •Mayo Clinic

 
Powered by Modern Medicine Advanstar Medical Communications Group